Fingerprint
Dive into the research topics of 'Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically